会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • METHOD OF DETERMINING A RELIABILITY INDICATOR FOR SIGNATURES OBTAINED FROM CLINICAL DATA AND USE OF THE RELIABILITY INDICATOR FOR FAVORING ONE SIGNATURE OVER THE OTHER
    • 确定从临床数据中获取的标志的可靠性指标的方法和使用可靠性指标,以便在其他人身上获得一个签名
    • US20110173201A1
    • 2011-07-14
    • US13119742
    • 2009-09-24
    • Angel JanevskiNilanjana BanerjeeYasser AlsafadiVinay Varadan
    • Angel JanevskiNilanjana BanerjeeYasser AlsafadiVinay Varadan
    • G06F17/30
    • G06F19/24G06F19/00G16H50/20G16H50/70
    • This invention relates to a method and an apparatus for determining a reliability indicator for at least one set of signatures obtained from clinical data collected from a group of samples. The signatures are obtained by detecting characteristics in the clinical data from the group of sample sand each of the signatures generate a first set of stratification values that stratify the group of samples. At least one additional and parallel stratification source to the signatures obtained from group of sample sis provided, the at least one additional and parallel stratification source to the signatures being independent from the signatures and generates a second set of stratification values. A comparison is done for each respective sample, where the first stratification values are compared with a true reference stratification values, and where the second stratification values are compared with the true reference stratification values. The signatures are assigned with similarity measure indicators indicating whether the first and the second stratification values match with the true reference stratification values. These are then implementing as input in determining the reliability of the signatures.
    • 本发明涉及一种用于确定从从一组样本收集的临床数据中获得的至少一组签名的可靠性指标的方法和装置。 通过检测来自样品组的临床数据的特征来获得这些特征,每个签名产生分层样本的第一组分层值。 至少一个附加和平行分层源提供从样本组提供的签名,所述签名的至少一个附加和平行分层源独立于签名并产生第二组分层值。 对每个相应的样本进行比较,其中将第一分层值与真实的参考分层值进行比较,并且将第二分层值与真实的参考分层值进行比较。 赋予签名的相似性度量指示符指示第一和第二分层值是否与真实的参考分层值相匹配。 然后在确定签名的可靠性时,将其作为输入。
    • 14. 发明授权
    • System and method for multiple-factor selection
    • 多因素选择的系统和方法
    • US08290715B2
    • 2012-10-16
    • US12133045
    • 2008-06-04
    • Dimitris AnastassiouVinay Varadan
    • Dimitris AnastassiouVinay Varadan
    • A61B5/00G01N33/48G01N33/00G06F19/00
    • G06F19/24G06F19/20
    • The disclosed subject matter provides techniques for multiple-factor selection. The factors can be features or elements that are jointly associated with one or more outcomes by their joint presence or absence. There may be a non-causative correlation between the factors, features, or elements and the outcomes. In some embodiments, Entropy Minimization and Boolean Parsimony (EMBP) is used to identify modules of genes jointly associated with disease from gene expression data, and a logic function is provided to connect the combined expression levels in each gene module with the presence of disease. The smallest module of genes whose joint expression levels can predict the presence of disease can be identified.
    • 所公开的主题提供了多因素选择的技术。 这些因素可以是通过其联合存在或不存在与一个或多个结果共同相关联的特征或元件。 因素,特征或要素与结果之间可能存在非因果关系。 在一些实施方案中,使用熵最小化和布尔参数(EMBP)来鉴定与基因表达数据共同与疾病相关联的基因的模块,并且提供逻辑功能以将每个基因模块中的组合表达水平与疾病的存在相关联。 可以确定其联合表达水平可以预测疾病存在的最小的基因组。
    • 15. 发明申请
    • SYSTEM AND METHOD FOR MULTIPLE-FACTOR SELECTION
    • 多因素选择的系统与方法
    • US20120253686A1
    • 2012-10-04
    • US13489334
    • 2012-06-05
    • Dimitris AnastassiouVinay Varadan
    • Dimitris AnastassiouVinay Varadan
    • G06F19/24
    • G16B40/00G16B25/00
    • The disclosed subject matter provides techniques for multiple-factor selection. The factors can be features or elements that are jointly associated with one or more outcomes by their joint presence or absence. There may be a non-causative correlation between the factors, features, or elements and the outcomes. In some embodiments, Entropy Minimization and Boolean Parsimony (EMBP) is used to identify modules of genes jointly associated with disease from gene expression data, and a logic function is provided to connect the combined expression levels in each gene module with the presence of disease. The smallest module of genes whose joint expression levels can predict the presence of disease can be identified.
    • 所公开的主题提供了多因素选择的技术。 这些因素可以是通过其联合存在或不存在与一个或多个结果共同相关联的特征或元件。 因素,特征或要素与结果之间可能存在非因果关系。 在一些实施方案中,使用熵最小化和布尔参数(EMBP)来鉴定与基因表达数据共同与疾病相关联的基因的模块,并且提供逻辑功能以将每个基因模块中的组合表达水平与疾病的存在相关联。 可以确定其联合表达水平可以预测疾病存在的最小的基因组。
    • 18. 发明申请
    • System And Method For Multiple-Factor Selection
    • 多因素选择的系统和方法
    • US20080300799A1
    • 2008-12-04
    • US12133045
    • 2008-06-04
    • Dimitris AnastassiouVinay Varadan
    • Dimitris AnastassiouVinay Varadan
    • G06F19/00G06F15/00
    • G06F19/24G06F19/20
    • The disclosed subject matter provides techniques for multiple-factor selection. The factors can be features or elements that are jointly associated with one or more outcomes by their joint presence or absence. There may be a non-causative correlation between the factors, features, or elements and the outcomes. In some embodiments, Entropy Minimization and Boolean Parsimony (EMBP) is used to identify modules of genes jointly associated with disease from gene expression data, and a logic function is provided to connect the combined expression levels in each gene module with the presence of disease. The smallest module of genes whose joint expression levels can predict the presence of disease can be identified.
    • 所公开的主题提供了多因素选择的技术。 这些因素可以是通过其联合存在或不存在与一个或多个结果共同相关联的特征或元件。 因素,特征或要素与结果之间可能存在非因果关系。 在一些实施方案中,使用熵最小化和布尔参数(EMBP)来鉴定与基因表达数据共同与疾病相关联的基因的模块,并且提供逻辑功能以将每个基因模块中的组合表达水平与疾病的存在相关联。 可以确定其联合表达水平可以预测疾病存在的最小的基因组。